Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
Antar AAR, Yu T, Demko ZO, Hu C, Tornheim JA, Blair PW, Thomas DL, Manabe YC; OutSMART Study Group. Antar AAR, et al. Among authors: thomas dl. medRxiv [Preprint]. 2023 Jan 19:2023.01.18.23284742. doi: 10.1101/2023.01.18.23284742. medRxiv. 2023. Update in: Front Immunol. 2023 Apr 28;14:1147549. doi: 10.3389/fimmu.2023.1147549 PMID: 36711478 Free PMC article. Updated. Preprint.
Optimal Decision Theory for Diagnostic Testing: Minimizing Indeterminate Classes with Applications to Saliva-Based SARS-CoV-2 Antibody Assays.
Patrone PN, Bedekar P, Pisanic N, Manabe YC, Thomas DL, Heaney CD, Kearsley AJ. Patrone PN, et al. Among authors: thomas dl. ArXiv [Preprint]. 2022 Jan 31:arXiv:2202.00494v1. ArXiv. 2022. Update in: Math Biosci. 2022 Sep;351:108858. doi: 10.1016/j.mbs.2022.108858 PMID: 35132382 Free PMC article. Updated. Preprint.
Modeling in higher dimensions to improve diagnostic testing accuracy: theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays.
Luke RA, Kearsley AJ, Pisanic N, Manabe YC, Thomas DL, Heaney CD, Patrone PN. Luke RA, et al. Among authors: thomas dl. ArXiv [Preprint]. 2022 Jun 28:arXiv:2206.14316v2. ArXiv. 2022. Update in: PLoS One. 2023 Mar 13;18(3):e0280823. doi: 10.1371/journal.pone.0280823 PMID: 35795812 Free PMC article. Updated. Preprint.
Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection.
Demko ZO, Yu T, Mullapudi SK, Varela Heslin MG, Dorsey CA, Payton CB, Tornheim JA, Blair PW, Mehta SH, Thomas DL, Manabe YC, Antar AAR; OutSMART Study Team. Demko ZO, et al. Among authors: thomas dl. medRxiv [Preprint]. 2022 Aug 9:2022.08.08.22278543. doi: 10.1101/2022.08.08.22278543. medRxiv. 2022. Update in: Open Forum Infect Dis. 2024 Mar 06;11(3):ofae027. doi: 10.1093/ofid/ofae027 PMID: 35982674 Free PMC article. Updated. Preprint.
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses.
Pisanic N, Antar AAR, Kruczynski K, Rivera MG, Dhakal S, Spicer K, Randad PR, Pekosz A, Klein SL, Betenbaugh MJ, Detrick B, Clarke W, Thomas DL, Manabe YC, Heaney CD. Pisanic N, et al. Among authors: thomas dl. medRxiv [Preprint]. 2022 Dec 26:2022.12.22.22283858. doi: 10.1101/2022.12.22.22283858. medRxiv. 2022. Update in: J Immunol Methods. 2023 Mar;514:113440. doi: 10.1016/j.jim.2023.113440 PMID: 36597525 Free PMC article. Updated. Preprint.
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6-12 Months Postinfection.
Demko ZO, Yu T, Mullapudi SK, Varela Heslin MG, Dorsey CA, Payton CB, Tornheim JA, Blair PW, Mehta SH, Thomas DL, Manabe YC, Antar AAR. Demko ZO, et al. Among authors: thomas dl. Open Forum Infect Dis. 2024 Mar 6;11(3):ofae027. doi: 10.1093/ofid/ofae027. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38449921 Free PMC article.
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution.
Pisanic N, Antar AAR, Hetrich MK, Demko ZO, Zhang X, Spicer K, Kruczynski KL, Detrick B, Clarke W, Knoll MD, Thomas DL, Dawood FS, Veguilla V, Karron RA, Manabe YC, Heaney CD. Pisanic N, et al. Among authors: thomas dl. J Infect Dis. 2024 Sep 12:jiae447. doi: 10.1093/infdis/jiae447. Online ahead of print. J Infect Dis. 2024. PMID: 39269503
A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: Design and Baseline Characteristics of the STOP-C Trial.
Mehta SH, Lau BM, Ehrhardt S, McFall A, Gunaratne MP, Baishya J, Kedar A, Srikrishnan AK, Evans J, Loeb T, Pradeep A, Kumar MS, Thomas DL, Lucas GM, Solomon SS. Mehta SH, et al. Among authors: thomas dl. Am J Epidemiol. 2024 Nov 8:kwae430. doi: 10.1093/aje/kwae430. Online ahead of print. Am J Epidemiol. 2024. PMID: 39572371
770 results